J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

Johnson & Johnson has been given FDA approval for Akeega, a combination tablet for first-line treatment of adults with BRCA-positive metastatic castration-resistant prostate cancer (mCRPC). The ...

The EMA’s human medicines committee has recommended approval for Akeega, a fixed-dose combination of J&J’s PARP drug Zejula (niraparib) and androgen inhibitor Zytiga (abiraterone acetate), in ...

ASCO 2025 First PARP Inhibitor Combo to Show Benefit in mCSPC Johnson & Johnson's AKEEGA® (niraparib + abiraterone acetate) is the first PARP-based combination to demonstrate statistically significant ...

Learn about uses and more of amitriptyline hydrochloride, a prescription tablet that treats depression in adults and some children.

Scott Bessent, US Treasury Secretary, gave a statement noting that the market resilience has shown that the tariffs haven’t ...

Ivermectin, which is used to treat certain parasitic infections, can cause side effects. Learn about its mild and serious side effects and how to manage them.

Samsung has revealed the Galaxy Watch 8 series, officially announcing both the Galaxy Watch 8 and Galaxy Watch 8 Classic on July 9. The Galaxy Watch 8 ...

The Google Pixel 10 Pro Fold is coming, and here's what you can expect. We're rounding up all the relevant leaks that surfaced thus far.

The 12-inch Surface Pro offers a sleek, refreshed form, and the battery-efficient Snapdragon X chip. Right now, it's on sale for $699 during Amazon Prime Day.